Literature DB >> 18442832

Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships.

David S Knopman1, Thomas H Mosley, Kent R Bailey, Clifford R Jack, Gary L Schwartz, Stephen T Turner.   

Abstract

BACKGROUND: Because of similarities between brain and kidney microvascular disease, there may be a relationship between measures of renal microvascular disease and brain structural changes in middle aged or elderly individuals.
OBJECTIVE: To determine whether the urine albumin/creatinine ratio (UACR), a measure of renal microvascular disease, is associated with brain atrophy and white matter hyperintensities.
METHODS: As part of a larger study of the genetics of hypertension, we performed brain imaging and assessed microalbuminuria and other vascular risk factors including diabetes, hypertension, hyperlipidemia and hyperhomocysteinemia in 1253 individuals from hypertensive sibships (age mean 63.8 years, range 50 to 91; 65% women; 49% African-American; 78% hypertensive). Semi-automated quantitative measurements of brain atrophy (BA) ventricular volume, and white matter hyperintensities (WMH) were carried out on the brain MR scans.
RESULTS: In logistic regression models, elevated UACR was associated with greater BA (odds ratio (OR)=1.70 (95% CI 1.14, 2.54) and burden of WMH (OR=2.06 (95% CI 1.37, 3.10) after controlling for demographic factors, blood glucose, hypertension severity, duration of smoking and serum homocysteine. In contrast to elevated UACR, the associations with elevated creatinine or reduced glomerular filtration rate and WMH were not significant in the fully adjusted models.
CONCLUSIONS: In this cohort with an overrepresentation of hypertensives, elevated UACR was independently associated with both brain atrophy and white matter hyperintensities. Brain volume loss and WMH burden might represent expressions of microvascular disease that share common mechanisms with nephrosclerosis.

Entities:  

Mesh:

Year:  2008        PMID: 18442832      PMCID: PMC2527625          DOI: 10.1016/j.jns.2008.03.009

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  40 in total

1.  Homocysteine and brain atrophy on MRI of non-demented elderly.

Authors:  T den Heijer; S E Vermeer; R Clarke; M Oudkerk; P J Koudstaal; A Hofman; M M B Breteler
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

2.  Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3,301 elderly people. The Cardiovascular Health Study. Collaborative Research Group.

Authors:  W T Longstreth; A M Arnold; T A Manolio; G L Burke; N Bryan; C A Jungreis; D O'Leary; P L Enright; L Fried
Journal:  Neuroepidemiology       Date:  2000 Jan-Feb       Impact factor: 3.282

3.  Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants.

Authors:  Lon White; Helen Petrovitch; John Hardman; James Nelson; Daron G Davis; G Webster Ross; Kamal Masaki; Lenore Launer; William R Markesbery
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

4.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

Review 5.  Neuropathology of white matter lesions in vascular cognitive impairment.

Authors:  Elisabet Englund
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

6.  Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects.

Authors:  Manabu Wada; Hikaru Nagasawa; Keiji Kurita; Shingo Koyama; Shigeki Arawaka; Toru Kawanami; Katsushi Tajima; Makoto Daimon; Takeo Kato
Journal:  J Neurol Sci       Date:  2007-02-23       Impact factor: 3.181

Review 7.  Neuropathologic substrates of ischemic vascular dementia.

Authors:  H V Vinters; W G Ellis; C Zarow; B W Zaias; W J Jagust; W J Mack; H C Chui
Journal:  J Neuropathol Exp Neurol       Date:  2000-11       Impact factor: 3.685

8.  Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study.

Authors:  Sarah E Vermeer; Ewoud J van Dijk; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Robert Clarke; Monique M B Breteler
Journal:  Ann Neurol       Date:  2002-03       Impact factor: 10.422

9.  Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; F Javier Nieto; Lori L Boland; David J Couper; Thomas H Mosley; Barbara E K Klein; Larry D Hubbard; Moyses Szklo
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

10.  FLAIR histogram segmentation for measurement of leukoaraiosis volume.

Authors:  C R Jack; P C O'Brien; D W Rettman; M M Shiung; Y Xu; R Muthupillai; A Manduca; R Avula; B J Erickson
Journal:  J Magn Reson Imaging       Date:  2001-12       Impact factor: 4.813

View more
  41 in total

1.  Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.

Authors:  Mariana Murea; Fang-Chi Hsu; Amanda J Cox; Christina E Hugenschmidt; Jianzhao Xu; Jeremy N Adams; Laura M Raffield; Christopher T Whitlow; Joseph A Maldjian; Donald W Bowden; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2015-02-26       Impact factor: 5.992

Review 2.  Vascular risk factors: imaging and neuropathologic correlates.

Authors:  David S Knopman; Rosebud Roberts
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.

Authors:  Manjula Kurella Tamura; Nicholas M Pajewski; R Nick Bryan; Daniel E Weiner; Matthew Diamond; Peter Van Buren; Addison Taylor; Srinivasan Beddhu; Clive Rosendorff; Hesamoddin Jahanian; Greg Zaharchuk
Journal:  Neurology       Date:  2016-02-26       Impact factor: 9.910

4.  Association of cognitive function with albuminuria and eGFR in the general population.

Authors:  Hanneke Joosten; Gerbrand J Izaks; Joris P J Slaets; Paul E de Jong; Sipke T Visser; Henk J G Bilo; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 8.237

5.  Mid-life proteinuria and late-life cognitive function and dementia in elderly men: the Honolulu-Asia Aging Study.

Authors:  Masaya Higuchi; Randi Chen; Robert D Abbott; Christina Bell; Lenore Launer; G Webster Ross; Helen Petrovitch; Kamal Masaki
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jul-Sep       Impact factor: 2.703

6.  A comparison of manual tracing and FreeSurfer for estimating hippocampal volume over the adult lifespan.

Authors:  Mike F Schmidt; Judd M Storrs; Kevin B Freeman; Clifford R Jack; Stephen T Turner; Michael E Griswold; Thomas H Mosley
Journal:  Hum Brain Mapp       Date:  2018-02-21       Impact factor: 5.038

Review 7.  Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability.

Authors:  A Vilar-Bergua; I Riba-Llena; C Nafría; A Bustamante; V Llombart; P Delgado; J Montaner
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

8.  Albuminuria and the risk of incident stroke and stroke types in older adults.

Authors:  M I Aguilar; E S O'Meara; S Seliger; W T Longstreth; R G Hart; P E Pergola; M G Shlipak; R Katz; M J Sarnak; D E Rifkin
Journal:  Neurology       Date:  2010-09-01       Impact factor: 9.910

9.  Losartan improved respiratory function and coenzyme Q content in brain mitochondria of young spontaneously hypertensive rats.

Authors:  Z Sumbalová; J Kucharská; F Kristek
Journal:  Cell Mol Neurobiol       Date:  2010-02-10       Impact factor: 5.046

10.  Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension.

Authors:  Mahyar Khaleghi; Umer Saleem; Nils G Morgenthaler; Stephen T Turner; Andreas Bergmann; Joachim Struck; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2009-02-12       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.